Table 4.
MLHFQ | EQ‐5D‐3L | KCCQ | ||||
---|---|---|---|---|---|---|
Β coefficient | P‐value | Β coefficient | P‐value | Β coefficient | P‐value | |
Age | −0.054 | 0.789 | −0.001 | 0.602 | −0.025 | 0.895 |
Gender | 8.091 | 0.119 | 0.033 | 0.545 | −5.626 | 0.225 |
BMI | 0.301 | 0.418 | −0.007 | 0.093 | −0.450 | 0.183 |
Systolic BP | 0.095 | 0.322 | 0.000 | 0.656 | −0.042 | 0.604 |
Heart rate | 0.168 | 0.256 | −0.002 | 0.283 | −0.170 | 0.211 |
LVEF | −0.316 | 0.100 | −0.004 | 0.082 | 0.142 | 0.393 |
NYHA class | 18.115 | 0.000 | −0.206 | 0.000 | −23.890 | 0.000 |
eGFR, mL/min | 0.191 | 0.095 | −0.002 | 0.096 | −0.178 | 0.090 |
BNP | −0.005 | 0.467 | 2.451E‐5 | 0.735 | 0.009 | 0.163 |
No. of co‐morbidities | 0.958 | 0.758 | 0.035 | 0.284 | −0.253 | 0.928 |
BMI, body mass index (kg/m2); BNP, B‐type natriuretic peptide; BP, blood pressure; eGFR, estimated glomerular filtration rate; EQ‐5D‐3L, EuroQoL 5D‐3L; KCCQ, Kansas City Cardiomyopathy Questionnaire; LVEF, left ventricular ejection fraction; MLHFQ, Minnesota Living with Heart Failure Questionnaire; NYHA, New York Heart Association.